Most Recent
IP Australia has ruled in favour of supplement maker Nature’s Way, finding that the registration of a Chinese competitor’s ‘Nature’s Bay’ trade mark was likely to cause consumer confusion.
A Sydney-based spice wholesaler has lost its bid to register a trade mark containing the word 'Tadka', with a delegate finding the word describes an Indian cooking technique.
AstraZeneca has attacked generic drugmaker Pharmacor’s challenge to a patent extension for its diabetes drug Forxiga, telling a judge that it hinges on the false notion that the protected IP is limited to a single molecule.
Target has lodged an appeal after an IP Australia delegate rejected its opposition to a e-commerce merchandise importer's bid to register a diagonal arrow as a trade mark.
The High Court of New Zealand has refused to grant New Zealand Rugby an interim injunction preventing the Australian Rugby League Commission from using the names 'PNG Chiefs' or 'Chiefs' in New Zealand.
Kmart is fighting a fintech's application to register a trade mark featuring a chevron shape and the letter 'k', arguing the application was made in bad faith.
Swedish IP services group Abion has purchased Brandsec's corporate domain management business, as it targets further growth across the Asia-Pacific region.
AstraZeneca has denied claims by Pharmacor that a patent for its diabetes drug Forxiga is invalid and that an extension of the patent's term was wrongly granted.
Adelaide-based Mayne Pharma Group has settled its dispute with generic drug maker Teva Pharmaceuticals over patents covering hormone replacement drug IMVEXXY.
Animal health giant Abbey Laboratories has fought off a challenge to its bid to register 'Virkill' as a trade mark for its disinfectant products, despite an IP Australia delegate finding the name was deceptively similar to its opponent's 'Virukill' mark.